What Are Neuropeptides?

Methods in Molecular Biology

Volumn 789, Issue , 2011, Pages 1-36

  Burbach, J Peter H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adipose peptides; Cerebellins; Chemokines; Granins; Neuropeptide synthesis

Indexed keywords

CEREBELLIN; CHEMOKINE; CHROMOGRANIN; NERVE PROTEIN; NEUROPEPTIDE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; GENETICS; HUMAN; METABOLISM;

ANIMALS; CHEMOKINES; CHROMOGRANINS; HUMANS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEUROPEPTIDES;

MAMMALIA;

EID: 80054723115     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-310-3_1     Document Type: Chapter

References (46)

1. Klavdieva, M.M. (1995) The history of neuropeptides 1. Front. Neuroendocrinol. 16, 293–321.
2. Klavdieva, M.M. (1996) The history of neuropeptides II. Front. Neuroendocrinol. 17, 126–153.
3. Klavdieva, M.M. (1996) The history of neuropeptides III. Front. Neuroendocrinol. 17, 155–179.
4. Klavdieva, M.M. (1996) The history of neuropeptides IV. Front. Neuroendocrinol. 17, 247–280.
5. Bayliss, W.M., and Starling, E.H. (1902) The mechanism of pancreatic secretion. J. Physiol. 28, 325–353.
6. Oliver, C., and Shäfer, E.A. (1895) On the physiological actions of extracts of the pituitary body and certain other glandular organs. J. Physiol. 18, 277–279.
7. Von den Velden, R. (1913) Die Nierenwirkung von Hypophysenextrakten beim Menschen. Klin. Wochschr. (Berlin) 50, 2083–2086.
8. Starling, E.H. (1904) The chemical regulation of the secretory process (Croonian Lecture to the Royal Society). Proc. Royal Soc. 73B, 310–322.
9. Starling, E.H. (1905) Croonian Lecture: On the chemical correlation of the functions of the body I. Lancet 2, 339–341.
10. Starling, E.H. (1905) Croonian Lecture: On the chemical correlation of the functions of the body II. Lancet 2, 423–425.
11. Starling, E.H. (1905) Croonian Lecture: On the chemical correlation of the functions of the body III. Lancet 2, 501–503.
12. Starling, E.H. (1905) Croonian Lecture: On the chemical correlation of the functions of the body IV. Lancet 2, 579–583.
13. Von Euler, U.S., and Gaddum J.H. (1931) An unidentified depressor substance in certain tissue extracts. J. Physiol. 72, 74–87.
14. Du Vigneaud, V., Lawler, H.C., and Popenoe, E.A. (1953) Enzymatic cleavage of glycinamide from vasopressin and a proposed structure for this pressor-antidiuretic hormone of the posterior pituitary. J. Am. Chem. Soc. 75, 4880–4881.
15. Wade, N. (1981) The Nobel Duel. Doubleday, Garden City, New York.
16. Tatemoto, K., and Mutt, V. (1980) Isolation of two novel candidate hormones using a chemical method for finding naturally occurring poly-peptides. Nature 285, 417–418.
17. Hughes, J., Smith, T.W., Kosterlitz, H.W. et al (1975) Identification of two related pentapep-tides from the brain with potent opiate agonist activity. Nature 258, 577–580.
18. Speidel, C.C. (1919) Gland-cells of internal secretion in the spinal cord of the skaes. Carengie Institute Washington Publications 13, 1–31
19. Scharrer, E., and Scharrer, B. (1937) Über Drüsen-Nervenzellen und neurosekretorische Organe bei Wirbellosen und Wirbeltieren. Biol. Rev. 12, 185–216.
20. Sterba, G. (1964) Principles of histochemical and biochemical demonstration of neurosecre-tion (carrier protein of oxytocin) with pseudoi-socyanine. Acta Histochem. 17, 268–92.
21. Bargmann W, Scharrer E (1951) The site of origin of the hormones of the posterior pituitary. Am. Sci. 39, 255–259.
22. Hökfelt, T., Johansson, O., Ljungdahl, A., Lundberg, J.M., and Schultzberg, M. (1980) Peptidergic neurones. Nature 284, 515–521.
23. Bohus, B., and De Wied, D. (1966) Inhibitory and facilitatory effect of two related peptides on extinction of avoidance behavior. Science 153, 318–320.
24. De Wied, D. (1969) Effects of peptide hormones on behavior. In: Ganong, W.F., and Martini, L. (eds), Frontiers in neuroendocrinology. Oxford University Press, New York, pp. 97–140.
25. De Wied, D. (1971) Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats. Nature 232, 58–60.
26. Brownstein, M.J. (1977) Studies of the distribution of biologically active peptides in the brain. Adv. Exp. Med. Biol. 87, 41–48.
27. Hur, Y.S., Kim, K.D., Paek, S.H. et al (2010) Evidence for the existence of secretory granule (dense-core vesicle)-based inositol 1,4,5-tris-phosphate-dependent Ca2+ signaling system in astrocytes. PLoS One 5, e11973.
28. Lonka-Nevalaita, L., Lume, M., Leppanen, S. et al (2010) Characterization of the intracellular localization, processing, and secretion of two glial cell line-derived neurotrophic factor splice isoforms. J. Neurosci. 30, 11403–11413.
29. Brownstein, M.J., Russell, J.T., and Gainer, H. (1980) Synthesis, transport, and release of posterior pituitary hormones. Science 207, 373–378.
30. Tooze, S.A., and Huttner, W.B. (1990) Cell-free protein sorting to the regulated and constitutive secretory pathways. Cell 60, 837–847.
31. Lang, T., Wacker, I., Steyer, J. et al (1997) Ca2+−triggered peptide secretion in single cells imaged with green fluorescent protein and eva-nescent-wave microscopy. Neuron 18, 857–863.
32. Tooze, S.A., Martens, G.J., and Huttner, W.B. (2001) Secretory granule biogenesis: rafting to the SNARE. Trends Cell Biol. 11, 116–122.
33. Burbach, J.P.H., and Wiegant, V.M. (1990) Gene expression, biosynthesis and processing of proopiomelanocortin peptides and vasopressin. In: De Wied, D. (ed), Neuropeptides, basics and perspectives. Elsevier, Amsterdam, pp 45–103.
34. 34., S.G., Jonas, V., Rosenfeld, M.G. et al (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298, 240–244.
35. Nawa, H., Kotani, H., Nakanishi, S. (1984) Tissue-specific generation of two preprotachy-kinin mRNAs from one gene by alternative RNA splicing. Nature 312, 729–734.
36. Zhao, E., Zhang, D., Basak, A. et al (2009) New insights into granin-derived peptides: evolution and endocrine roles. Gen. Comp. Endocrinol. 164, 161–174.
37. Braks, J.A., and Martens, G.J. (1994) 7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretory pathway. Cell 78, 263–273.
38. Ubogu, E.E., Cossoy, M.B., and Ransohoff, R.M. (2006) The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 27, 48–55.
39. de Haas, A.H., van Weering, H.R., de Jong, E.K. et al (2007) Neuronal chemokines:versatile messengers in central nervous system cell interaction. Mol Neurobiol. 36, 137–151.
40. Miller, R.J., Rostene, W., Apartis, E. et al (2008) Chemokine action in the nervous system. J. Neurosci. 28, 11792–11795.
41. Huang, E.J., and Reichardt, L.F. (2001) Neurotrophins:roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677–736.
42. Thomas, K., and Davies, A. (2005) Neurotrophins:a ticket to ride for BDNF. Curr. Biol. 15, R262-R264.
43. Salio, C., Averill, S., Priestley, J.V. et al (2007) Costorage of BDNF and neuropeptides within individual dense-core vesicles in central and peripheral neurons. Dev. Neurobiol. 67, 326–338.
44. Yang, J., Siao, C.J., Nagappan, G. et al (2009) Neuronal release of pro-BDNF. Nat. Neurosci. 12, 113–115.
45. Teng, H.K., Teng, K.K., Lee, R. et al (2005) Pro-BDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 25, 5455–5463.
46. Dicou, E, (2007) Peptides other than the neurotrophins that can be cleaved from proneurotrophins:a neglected story. Arch. Physiol. Biochem. 113, 228–233.